Valuation: Psychemedics Corporation

Market Cap 9.79M 8.7M 8.12M 7.4M 13.96M 941M 14.09M 98.26M 38.08M 481M 36.76M 35.96M 1.54B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.48M 7.91M 7.21M 13.6M 917M 13.73M 95.74M 37.1M 469M 35.82M 35.04M 1.5B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+47.69%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+13.31%-34.96% 15.26M
+1.48%-3.00%+11.63%+24.06% 111B
+0.78%-2.05%0.00%+72.60% 92.38B
+0.46%-0.54%+156.13%+839.45% 59.15B
-0.38%-5.45%-7.18%+53.64% 27.66B
+0.97%-1.27%+28.94%+92.98% 25.75B
+1.28%-0.37%+10.40%+54.59% 25.02B
-0.57%+0.09%-15.78%-7.70% 20.99B
+1.83%-0.42%+27.16%+290.84% 20.82B
+1.30%-2.86%-5.57%+34.95% 16.87B
Average +0.72%-1.65%+21.90%+142.04% 39.92B
Weighted average by Cap. +0.90%-2.05%+28.73%+177.21%

Financials

2023 2024
Net sales 22.1M 19.63M 18.33M 16.7M 31.5M 2.12B 31.79M 222M 85.93M 1.09B 82.97M 81.17M 3.49B 19.68M 17.49M 16.32M 14.88M 28.06M 1.89B 28.32M 198M 76.55M 967M 73.91M 72.3M 3.1B
Net income -4.15M -3.69M -3.44M -3.14M -5.92M -399M -5.98M -41.69M -16.15M -204M -15.6M -15.26M -655M -1.86M -1.65M -1.54M -1.41M -2.65M -179M -2.68M -18.68M -7.24M -91.46M -6.99M -6.84M -294M
Net Debt 334K 297K 277K 252K 476K 32.11M 481K 3.35M 1.3M 16.41M 1.25M 1.23M 52.68M -251K -223K -208K -190K -358K -24.13M -361K -2.52M -976K -12.34M -942K -922K -39.59M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock